Physician profile
Robert Imel
NPI 1154850592
$1,568.41
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $27.94 · 2021: $54.91 · 2022: $93.71 · 2023: $1,392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,322 · Food and Beverage: $69.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,321.87 |
| Food and Beverage | $69.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,321.87 | 2023 | Da Vinci Surgical System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $93.86 | 2022-2023 | Ofev |
| La Jolla Pharmaceutical Company | $46.80 | 2021-2023 | Giapreza |
| Regeneron Healthcare Solutions, INC. | $29.23 | 2022 | |
| Gilead Sciences, INC. | $27.64 | 2021 | |
| Glaxosmithkline, LLC. | $21.07 | 2023 | Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $14.66 | 2020 | |
| Jazz Pharmaceuticals INC. | $13.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Imel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.